Value of prognostic nutritional index for survival prediction in trans-catheter aortic valve replacement compared to other common nutritional indexes.


Journal

Acta cardiologica
ISSN: 1784-973X
Titre abrégé: Acta Cardiol
Pays: England
ID NLM: 0370570

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 13 5 2020
medline: 26 11 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

Nutritional status predicts outcomes after TAVR. Predictive value of Prognostic Nutritional Index (PNI) was investigated in patients undergoing TAVR, and compared to other nutritional indexes. A cohort of 114 patients undergoing TAVR in a high-volume centre was studied. A prospective 1-year follow-up was completed. PNI was estimated as follows: (10 × serum albumin[g/dl])+(0.005 × total lymphocytes [1000/μl]). One-year survival was compared in patients with PNI above vs below median; Kaplan-Meier curves were created. A multivariate analysis was used to assess predictive value of PNI for 1-year mortality. ROC curves were used to assess discrimination by PNI, and to compare it with Geriatric Nutritional Risk Index (GNRI) and Body Mass Index (BMI). Mean age was 82.2 years, 59.6% were male. Mean PNI was 46 ± 5. Pre-procedurally, no differences were found between patients with high vs. low PNI. One-year mortality was significantly higher in patients with low PNI values (19/57 vs. 4/57; PNI is a useful and practical nutritional marker reflecting malnutrition and inflammation prior to the intervention, and strongly predicts 1-year survival. PNI seems to be a better prognostic marker than BMI or GNRI after TAVR.

Sections du résumé

BACKGROUND BACKGROUND
Nutritional status predicts outcomes after TAVR. Predictive value of Prognostic Nutritional Index (PNI) was investigated in patients undergoing TAVR, and compared to other nutritional indexes.
METHODS METHODS
A cohort of 114 patients undergoing TAVR in a high-volume centre was studied. A prospective 1-year follow-up was completed. PNI was estimated as follows: (10 × serum albumin[g/dl])+(0.005 × total lymphocytes [1000/μl]). One-year survival was compared in patients with PNI above vs below median; Kaplan-Meier curves were created. A multivariate analysis was used to assess predictive value of PNI for 1-year mortality. ROC curves were used to assess discrimination by PNI, and to compare it with Geriatric Nutritional Risk Index (GNRI) and Body Mass Index (BMI).
RESULTS RESULTS
Mean age was 82.2 years, 59.6% were male. Mean PNI was 46 ± 5. Pre-procedurally, no differences were found between patients with high vs. low PNI. One-year mortality was significantly higher in patients with low PNI values (19/57 vs. 4/57;
CONCLUSION CONCLUSIONS
PNI is a useful and practical nutritional marker reflecting malnutrition and inflammation prior to the intervention, and strongly predicts 1-year survival. PNI seems to be a better prognostic marker than BMI or GNRI after TAVR.

Identifiants

pubmed: 32396499
doi: 10.1080/00015385.2020.1757854
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

615-622

Auteurs

Silvia Mas-Peiro (S)

Department of Cardiology, University Hospital Frankfurt am Main, Frankfurt, Germany.
German Centre for Cardiovascular Research, DZHK, Berlin, Germany.

Jedrzej Hoffmann (J)

Department of Cardiology, University Hospital Frankfurt am Main, Frankfurt, Germany.
German Centre for Cardiovascular Research, DZHK, Berlin, Germany.

Philipp C Seppelt (PC)

Department of Cardiology, University Hospital Frankfurt am Main, Frankfurt, Germany.
German Centre for Cardiovascular Research, DZHK, Berlin, Germany.

Roberta De Rosa (R)

Department of Cardiology, University Hospital Frankfurt am Main, Frankfurt, Germany.

Marie-Isabel Murray (MI)

Department of Cardiology, University Hospital Frankfurt am Main, Frankfurt, Germany.

Thomas Walther (T)

German Centre for Cardiovascular Research, DZHK, Berlin, Germany.
Department of Cardiothoracic Surgery, University Hospital Frankfurt am Main, Frankfurt, Germany.

Andreas M Zeiher (AM)

Department of Cardiology, University Hospital Frankfurt am Main, Frankfurt, Germany.
German Centre for Cardiovascular Research, DZHK, Berlin, Germany.

Stephan Fichtlscherer (S)

Department of Cardiology, University Hospital Frankfurt am Main, Frankfurt, Germany.
German Centre for Cardiovascular Research, DZHK, Berlin, Germany.

Mariuca Vasa-Nicotera (M)

Department of Cardiology, University Hospital Frankfurt am Main, Frankfurt, Germany.
German Centre for Cardiovascular Research, DZHK, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH